ALINESS NAC N-Acetyl-L-Cysteine 190mg 100 tabl
- ALINESS NAC N-Acetyl-L-Cysteine 190 mg 100 tablets is a dietary supplement that supports immunity, detoxification, and oxidative stress reduction. It aids in cell regeneration, liver function, and muscle growth.
ALINESS NAC N-Acetyl-L-Cysteine 190 mg 100 tablets
- thins respiratory secretions, facilitating gas exchange
- effective for colds and flu
- supports liver function
- normalizes lipid levels
- supports physical effort, increases endurance, accelerates recovery
- accelerates muscle protein synthesis
ALINESS NAC N-Acetyl-L-Cysteine 190 mg 100 tablets - description
Dietary supplement in tablets. It exhibits a range of positive properties, including boosting the body's immunity, reducing the effects of oxidative stress, and contributing to the elimination of toxins from the body. Additionally, it supports muscle mass gain and exhibits anabolic effects.
One of NAC’s main actions is supporting the immune system. It acts as a powerful antioxidant, neutralizing free radicals and reducing oxidative stress, which can cause cell damage and accelerate the aging process. Regular use of NAC may improve the body's immunity, enhancing its ability to defend against infections and supporting cell regeneration.
Who is this product for?
The supplement is intended for people who want to support immunity, protection against oxidative stress, and body detoxification processes.
| Active ingredients | 1/2 tablet |
|---|---|
| N-acetyl-L-cysteine (NAC) | 190 mg |
| %RI – Reference Intake | |
Ingredients: N-acetyl-L-cysteine (NAC), capsule shell: (binding substance: hydroxypropylmethylcellulose).
Packaging: 100 tablets
Serving size: 1/2 tablet
Number of servings per package: 200
How to use
1/2 tablet during a meal.
Contraindications
Not recommended for pregnant women, breastfeeding mothers, or individuals allergic to any of the ingredients. The dietary supplement cannot be a substitute for a healthy lifestyle. Do not exceed the recommended daily dose.
Storage
Store in a dry, dark place out of reach of small children.
Responsible entity: MEDICALINE Konrad Malitka, NIP 532 169 09 62
